therapeutic silencing endogenous gene systemic administration modified sirnas 
rna interference rnai holds considerable promise therapeutic approach silence disease-causing genes particularly encode so-called non-druggable targets amenable conventional therapeutics small molecules proteins monoclonal antibodies main obstacle achieving vivo gene silencing rnai technologies delivery show chemically modified short interfering rnas sirnas can silence endogenous gene encoding apolipoprotein b apob intravenous injection mice administration chemically modified sirnas resulted silencing apob messenger rna liver jejunum decreased plasma levels apob protein reduced total cholesterol also show sirnas can silence human apob transgenic mouse model vivo study mechanism action sirnas proven occur rnai-mediated mrna degradation determined cleavage apob mrna occurred specifically predicted site findings demonstrate therapeutic potential sirnas treatment disease 
